ADC Therapeutics SA

NYSE: ADCT · Real-Time Price · USD
3.35
-0.24 (-6.69%)
At close: Jun 04, 2025, 3:59 PM
3.38
0.71%
After-hours: Jun 04, 2025, 04:36 PM EDT
-6.69%
Bid 3.14
Market Cap 332.74M
Revenue (ttm) 70.19M
Net Income (ttm) -149.84M
EPS (ttm) -1.42
PE Ratio (ttm) -2.36
Forward PE -2.54
Analyst Buy
Ask 3.5
Volume 751,988
Avg. Volume (20D) 489,960
Open 3.52
Previous Close 3.59
Day's Range 3.28 - 3.54
52-Week Range 1.05 - 4.13
Beta 1.96

About ADCT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADCT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ADCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+37.12%
ADC Therapeutics shares are trading higher after t... Unlock content with Pro Subscription
1 month ago
+9.77%
ADC Therapeutics shares are trading higher after the company announced data from preclinical studies of three exatecan-based antibody drug conjugates targeting Claudin-6, prostate-specific membrane antigen and Alanine, Serine, Cysteine Transporter 2